NCT06246227View on ClinicalTrials.gov

ctDNA for Early Detection of Recurrence in Melanoma

Active, not recruitingOBSERVATIONAL
Enrollment

467

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

October 6, 2027

Study Completion Date

January 1, 2028

Conditions
Melanoma
Trial Locations (1)

2730

Detp. of Pastic and Reconstructive Surgery, Herlev Hospital, Herlev

Sponsors
All Listed Sponsors
collaborator

Danish Cancer Society

OTHER

collaborator

Danish Cancer Research Foundation

OTHER

collaborator

DCCC ctDNA Research Center

UNKNOWN

collaborator

CAG in Cancer immunotherapy

UNKNOWN

lead

Herlev and Gentofte Hospital

OTHER